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Abstract
PURPOSE—Little is known about nonmedical use of prescription drugs among non-college 
attending young adults in the United States.
METHODS—Data was drawn from 36,781 young adults (ages 18–22 years) from the 2008–2010 
National Survey on Drug Use and Health public use files. The adjusted main effects for current 
educational attainment, along with its interaction with gender and race/ethnicity, were considered.
RESULTS—Compared to those attending college, non-college attending young adults with at 
least and less than a HS degree had a higher prevalence of past-year nonmedical use of 
prescription opioids (NMUPO: 13.1% and 13.2%, respectively, vs. 11.3%, adjusted Odds Ratios 
[aORs]: 1.21 [1.11–1.33] and 1.25 [1.12–1.40]), yet lower prevalence of prescription stimulant 
use. Among users, regardless of drug type, non-college attending youth were more likely to have 
past year disorder secondary to use (e.g., NMUPO: 17.4% and 19.1%, respectively, vs. 11.7%, 
aORs: 1.55 [1.22–1.98] and 1.75 [1.35–2.28]). Educational attainment interacted with gender and 
race: 1) among nonmedical users of prescription opioids, females who completed high school but 
were not enrolled in college had a significantly greater risk of opioid disorder (compared to female 
college students) than the same comparison for men; and 2) the risk for nonmedical use of 
prescription opioids was negligible across educational attainment groups for Hispanics, which was 
significantly different than the increased risk shown for Non-Hispanic whites.
CONCLUSIONS—There is a need for young adult prevention and intervention programs to 
target nonmedical prescription drug use beyond college campuses.
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Nonmedical prescription drug use - use without a prescription or use with a prescription but 
in a manner other than how prescribed – is the fastest growing drug problem in the United 
States [1], driven primarily by nonmedical use of prescription opioids (NMUPO) among 
younger cohorts [2]. While a large proportion of young adults (age 18–22) are prescribed 
opiates (PO) and stimulants for legitimate health conditions [3–7], NMUPO is second only 
to marijuana as the most prevalent form of illegal drug use among young adults, and a third 
of persons with opiate disorders secondary to PO use in 2011 were young adults [8]. 
Nonmedical use of prescription stimulants is also of concern among young adults [5–7,9]. 
Moreover, this age group is particularly vulnerable to the development of adverse substance 
using patterns, due in part to the process of identity formation that emerges at this 
developmental stage, and a greater level of independence compared to adolescence [10].
A limitation of many studies on nonmedical prescription drug use (particularly opiates) 
among young adults is that their samples are limited to select segments of the young adult 
population. For example, a few studies have examined NMUPO in community samples of 
high-risk young adults (i.e., injection drug users) in urban settings, but none of these studies 
have compared estimates to young adults in the general population [11–16]. Problems 
related to substance use on college campuses has also been a central focus of research on 
alcohol [17,18], nonmedical stimulant use [5–7,19–22], and NMPO [7,23,24] use among 
college students. However, many young adults are not seeking a college education [25]. It 
has been estimated that among those completing their secondary education, about 70% 
enroll in further education: 42% enroll in 4-year institutions and 28% at 2-year institutions 
right after graduating high school [26]. College-based studies also exclude significant 
proportions of minority young adults [27]. The National Center for Education Statistics 
indicates that high school dropout rates are particularly high for non-Hispanic (NH) black 
and Hispanic students, as well as for those who are the first in their family to attend college, 
and those who have limited English proficiency [28]. Nationally, about 75% of all students 
graduate from high school on time with a regular diploma, but barely half of non-Hispanic 
black and Hispanic students earn diplomas with their peers [29]. Thus, a substantial 
proportion of young adults fall outside the purview of college-based studies and there is a 
need to further compare the prevalence of nonmedical prescription use of opiates and 
stimulants and disorders secondary to their use by race/ethnicity between young adults who 
attend college versus those that do not attend college. Notably, most prevention programs to 
reduce substance use among young adults are designed for college settings; a comparison 
between college- and non-college attending young adults would illuminate specific issues 
that need to be adapted for prevention programs targeting non-college attending youth [30].
It is also important to investigate whether there are any racial/ethnic and male-female 
differences in NMUPO or nonmedical stimulant use within sub-groups of young adults with 
similar educational attainment levels. Lifetime and past-year drug use disorders have been 
consistently associated with lower educational attainment and minority status [31–35]. 
Studies suggest that individuals with less years of formal education are at high risk of 
becoming drug dependent [32,34] and of experiencing persistent dependence, in contrast to 
those with more years of formal education [34]. Among college students, whites are more 
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likely than students of other race/ethnicities to be nonmedical stimulant and prescription 
opioid users [5,7,23,24,36,37]. The evidence on potential gender differences in nonmedical 
prescription drug use among young adults has been mixed -- some studies find no 
difference, others have found a higher prevalence in males, and others in females 
[7,8,23,24,36–39]. Very few studies have investigated male-female differences in 
prescription stimulant and prescription opioid disorders secondary to nonmedical use in 
young adults [40,41]. Thus, examining how college attendance modifies gender differences 
might inform the mixed results on the association between gender and nonmedical 
prescription drug use. This study aims to examine racial/ethnic and male-female differences 
in nonmedical prescription use of opiates and stimulants as well as on disorders secondary to 
their use among young adults by different educational attainment.
The goals of this study are to explore whether nonmedical prescription drug use 
(specifically, opioids and stimulants) and disorders secondary to the drug use varies by 
education and examine race/ethnic and male-female differences within educational 
subgroups using data obtained from nationally representative samples of 18–22 year olds 
residing in the United States. Specifically, we sought to: (1) compare the 12-Month 
prevalence of nonmedical use of prescription opioids and stimulants as well as the 
prevalence of opioid and stimulant disorder secondary to nonmedical use among non-
college-attending young adults versus their college attending peers adjusting for 
demographics and past-year serious psychological distress, and (2) test for risk differences 
of nonmedical use and disorder among males and females separately and racial/ethnic 
groups stratified by educational attainment in this population. Our models also adjust for the 
presence of psychological distress because POs have been found to be used nonmedically to 
self-medicate negative emotions among young adults [42] and several studies have shown 
that NMUPO can be related to psychological distress in general population samples [43–48].
Materials and Methods
Study sample and measures
We analyzed data from 36,781 young adults between the ages of 18–22 from the 2008 
(n=57,739), 2009 (n=55,772), and 2010 (n=57,873) NSDUH public use files; three 
consecutive NSDUH years were combined in order to increase sample size. The NSDUH is 
an annual cross-sectional survey sponsored by the Substance Abuse and Mental Health 
Administration (SAMHSA) and is designed to provide estimates of the prevalence of drug 
use and disorders in the household population of the United States among those 12 years old 
and older [49]. Annually the survey selects an independent multistage area probability 
sample for each of the 50 states and the District of Columbia. African-Americans, 
Hispanics, and young people were over-sampled to increase the precision of estimates for 
these groups. The response rate for household screening was 88% and the weighted response 
rate was 74.8% for completed interviews across the three years [50]. Survey items were 
administered by computer-assisted personal interviewing (CAPI) conducted by an 
interviewer and audio computer-assisted self-interviewing (ACASI). Use of ACASI was 
designed to provide respondents with a highly private and confidential means of responding 
to questions and to increase the level of honest reporting of drug use and other sensitive 
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behaviors [51]. Respondents were offered a $30 incentive payment for participation in the 
survey. Detailed information about the sampling and survey methodology of NSDUH are 
found elsewhere [8,35,49]. All respondents provided information about their drug 
experiences and their socio-demographic characteristics. The NSDUH questionnaire 
instrument has sensitivity values ranging from 0.8–0.97 for most substances, and specificity 
values of 0.7–0.95 [35,52].
Outcome variables: nonmedical prescription opiate and stimulant use and disorders 
secondary to use
NMUPO was defined as any self-reported use of prescription pain relievers that were not 
prescribed for the respondent or that the respondent took only for the experience or feeling 
they caused [49]. In order to reduce false-positive responses, all respondents were given the 
following instructions: “These questions are about prescription pain reliever use. We are not 
interested in your use of over-the-counter pain relievers that can be bought in stores without 
a doctor’s prescription.” Past-year NMUPO was defined based on the response to the 
following question: ‘how long has it been since you last used any prescription pain reliever 
that was not prescribed for you or that you took only for the experience or feeling it caused.’ 
If the respondent answered positively, they were classified as a lifetime NMUPO user. Then, 
if the response indicated that nonmedical use occurred during the preceding 12 months, the 
respondent was classified as a past-year NMUPO user. The survey used discrete questions 
and a card with pictures of many types of prescription opioids. The respondents were asked 
which ones he/she had used, as well as frequency of use.
Similarly, the NSDUH used a screening question that assessed whether the respondent had 
ever used a prescription stimulant that was not prescribed, or taken one for the experience or 
feeling it caused. If the response was positive, the respondent was given a card with pictures 
of many types of prescription stimulant sand was asked which ones he/she had used, as well 
as frequency of use. Then, if the response indicated that nonmedical use occurred during the 
preceding 12 months, the respondent was classified as a past-year prescription stimulant 
user.
Respondents with NMUPO in the past-year were asked a set of 17 structured questions 
designed to operationalize DSM-IV criteria [53] for past-year opioid abuse and dependence 
secondary to NMUPO (referred together as OD secondary to NMUPO in this manuscript). 
Similar questions were asked to operationalize DSM-IV criteria [50] for past-year stimulant 
abuse and dependence secondary to prescription stimulant use (referred together as 
prescription stimulant disorder in this manuscript).
Primary exposure variable: Educational attainment
Current educational attainment was operationalized in the NSDUH as: 1) current college 
student, 2) high school graduate/GED [general education certification], 3) did not complete 
high school (this information was only asked for 18–22 year-old respondents). There was no 
information on whether respondents were attending 2-year (community colleges) or 4-year 
colleges.
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Demographic variables selected for this study included gender, race/ethnicity (non-Hispanic 
white, non-Hispanic African American, Native American/Hawaiian/Pacific Islander, Asian, 
more than one race, Hispanic), and whether they resided in a large metro, small metro or 
nonmetropolitan statistical area. We recognize that for some racial/ethnic groups sample 
sizes of respondents (particularly for disorders) will be small, but simply combining these 
groups into an “Other” group would prohibit us from exploring potential prevalence 
disparities that might exist.
Past-year serious psychological distress
Serious psychological distress (SPD) was measured using the Kessler 6 (K6) screening 
instrument for nonspecific psychological distress. The K6 scales were designed to maximize 
the ability to discriminate cases of SPD from non-cases [54]. The tool consists of 6 items, 
each with a 0–4 point rating scale that screens for general distress in the past year. It has 
excellent internal consistency and reliability (Cronbach’s alpha =0.89). In all years 
respondents were classified with past-year SPD if the totaled summed score was 13 or 
greater [54].
Statistical analyses
Data were weighted to reflect the complex design and multiple years of the NSDUH sample 
and were analyzed using Stata 11.0 [55] and SUDANN [59] software (specifically used for 
interaction-testing). We used Taylor series estimation methods to obtain proper standard 
error estimates for the cross-tabulations and logistic regressions. All percentages reported 
are weighted by study weights. Because we analyzed data from three NSDUH years 
combined, weights were divided by three (numbers of years of data combined) as 
recommended by SAMHSA [8]. Exploratory data analyses did not show any statistically 
significant differences in the NSDUH samples across years, justifying combining the data 
from multiple years. After basic contingency tables were created, we ran logistic models that 
included covariates (adjusted for demographics and past-year serious psychological distress) 
to compare the prevalence of past-year NMUPO, past-year nonmedical prescription 
stimulant use, past-year OD secondary to NMUPO, and past-year stimulant dependence 
secondary to nonmedical prescription stimulant use among college students aged 18–22 
versus their non-college student counterparts. Then, we tested for interactive effects between 
educational group status with both gender and race. Interaction was assessed on the additive 
scale by testing the interaction contrast (IC), which represents the difference in risk 
differences [56]. Adjusted ICs were calculated using the PRED_EFF command in SUDAAN 
[57].
Results
Estimated past-year prevalence by educational attainment (Table 1)
The prevalence estimates of past-year NMUPO among 18–22 year-old college students, 
those with high school diploma/GED and those with less than high school education were 
11.3%, 13.1% and 13.2%, respectively. Those with less than high school (aOR: 1.25 [1.12–
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1.40]) and those who completed high school/GED (aOR: 1.21 [1.11–1.33]) were more likely 
than college students to be past-year NMUPO (Table 1). Women were less likely than men 
to be past-year NMUPO (aOR: 0.74 [0.68–0.81]); NH blacks, NH Asians and Hispanics 
were less likely to use PO nonmedically in the past-year compared to NH whites; and 
respondents who reported past-year serious psychological distress were more likely than 
those without distress to report past-year NMUPO (aOR: 2.09 [1.89–2.31]). There were no 
differences in the prevalence of NMUPO or in the prevalence of OD secondary to NMUPO 
by county type.
In contrast, the prevalence estimates for past-year nonmedical stimulant use among 18–22 
year-old college students, those with a high school diploma/GED, and those with less than 
high school education were 4.8%, 3.1%, and 3.0%, respectively. Those with less than high 
school (aOR: 0.66 [0.54–0.80]) and those who completed high school/GED (aOR: 0.65 
[0.55–0.77]) were less likely to have been past-year nonmedical stimulant users compared to 
their college-attending peers (Table 1). As with prescription opioids, females, NH blacks, 
NH Asians, and Hispanics were less likely to report past-year nonmedical stimulant use, and 
respondents who reported past-year serious psychological distress were more likely than 
those without distress to report past-year nonmedical stimulant use.
Among young adults aged 18–22 year-old with past-year NMUPO, those with lower 
educational attainment (less than high school education: 19.1%, aOR: 1.75 [1.35–2.28], 
completed high school/GED: 17.4%, aOR: 1.55 [1.22–1.98]) were more likely to have past-
year OD compared to college students (Table 1). NH blacks were less likely than NH whites 
to have OD (aOR: 0.60[0.41–0.89]), but there were no racial/ethnic differences in the 
prevalence of OD between NH whites and those of other racial/ethnic groups. NMUPO 
users who reported past-year psychological distress were more likely to have OD than those 
with no psychological distress (aOR: 3.05 [2.40–3.88], Table 1).
Among young adults with past-year nonmedical stimulant use, a similar pattern with 
educational attainment was seen. Past-year stimulant use disorder was more likely among 
those with lower educational attainment (less than high school education: 17.9%, aOR: 2.39 
[1.35–4.12], completed high school/GED: 14.0%, aOR:1.75 [1.02–3.02]) compared to their 
college attending peers (Table 1). However, among past-year nonmedical stimulant users, 
NH Asians were more likely than whites to have developed past-year stimulant use disorder 
(aOR: 3.29 [1.17–9.24]), and those living in a non-metro county type were less likely to 
develop past-year stimulant use disorder (aOR: 0.54 [0.32–0.92]), compared to living in a 
large metro area.
Risk differences: educational attainment by gender (Table 2)
For both males and females, having less than a high school degree was associated with a 
greater risk of NMUPO use compared to their college attending counterparts (RD: 3.4%, p<.
001 for males, RD: 1.5%, p=0.072 for females). While a greater risk difference was 
observed for males, this association was not significantly different from that of females (IC: 
2.0%, p=0.069). Further, the relationship between educational attainment and past-year OD 
among PO users differed by gender. While the difference between male college students and 
males with a high school diploma/GED for past-year OD secondary to NMUPO was 
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negligible (RD: 1.7%, p=0.445), females with a high school diploma/GED had a much 
greater risk compared to their college-attending counterparts (RD: 8.2%, p<.001). In our test 
of additive interaction, the risk of OD secondary to NMUPO associated with educational 
attainment did significantly differ by gender (IC: −6.5%, p=0.050). For past-year 
nonmedical stimulant use, females with less than a high school degree were significantly 
less likely to report past-year nonmedical stimulant use than females with college education 
(RD: −2.2%, p<.001). There was less of an educational risk difference among males (RD: 
−0.8%, p-0.080).
Risk differences: educational attainment by race (Table 3)
The relationship between educational attainment and NMUPO was modified by race. 
Among NH whites, those with lower educational attainment had a significantly higher risk 
of NMUPO compared to college students (completed high school/GED, RD: 2.7%, p<.001; 
less than a high school (HS) degree, RD: 3.0%, p<.001). However, among Hispanics, NH 
blacks, NH more than one race and Asians there were no significant differences between 
either of the lower educational attainment groups and college students for risk of NMUPO 
(see Table 3). The risk differences for Hispanic groups were significantly different from 
those observed for their NH white counterparts (IC: −3.2%, p=0.031, IC: −3.0%, p=0.040, 
for completed HS/GED and less than a HS degree, respectively). Further, while the risk of 
NMUPO associated with educational attainment was much more pronounced among Native 
Americans/Pacific Islanders and Asians, these risk differences were not significantly 
different from those observed for their NH white counterparts. For past-year OD among 
NMUPO, the risk associated with educational attainment did not significantly differ by race.
For past-year nonmedical stimulant use, the risk differences between NH whites attending 
college compared to NH whites with less than a high school diploma (RD: −2.2%, p<.001) 
and NH whites with a high school diploma/GED (RD: −2.4, p<.001), was significantly 
greater than the same educational attainment comparisons among NH blacks (for less than 
high school degree, IC: 1.9%, p=0.002; for at least a high school diploma/GED, IC: 2.2%, 
p<.001) and among Hispanics (for less than high school degree, IC: 1.4%, p=0.031; for at 
least a high school diploma/GED, IC: 2.5%, p=0.004). For past-year stimulant use disorder 
among past-year stimulant users, the risk associated with educational attainment did not 
significantly differ by race.
Discussion
Findings from the study highlight the need to examine in greater detail the determinants of 
NMPO and both prescription stimulant and opioid disorders among young adults who are 
not in college. Past-year prevalence rates of NMUPO and OD secondary to NMUPO are 
higher in these subpopulations than among college students. These findings are in sharp 
contrast with the educational profile of nonmedical stimulant users in this age group. 
Consistent with reports from other studies [37,58,59], past-year prevalence of nonmedical 
prescription stimulant use is higher among college-attending young adults than among those 
that do not attend college. On the other hand, similar to our prescription opioid disorders 
findings, prescription stimulant disorders were more prevalent among nonmedical 
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prescription stimulant users who were non-college attending young adults as compared to 
their college-attending peers. These findings are in line with several other studies (with a 
focus on other substances) suggesting that individuals with lower levels of educational 
attainment are at high risk of developing drug use disorders [34,32,60]. It is important to 
note that over 40% of the nonmedical PO and stimulant users identified in the National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) data who initiated use 
of these drugs at 18 years of age or younger went on to develop prescription opioid and 
stimulant disorders [61]. Previous studies have already shown that users with more years of 
formal education tend to mature out of using drugs and may have more resources to seek 
help and reestablish their life again after becoming drug-involved, while that is often not the 
case among populations with fewer years of formal education [62,63].
Despite the fact that women were less likely than men to be past-year NMUPO, they were 
equally likely as men to have OD secondary to NMUPO. These findings are consistent with 
findings from general population studies [40]. Interestingly, the relationship between 
educational attainment and OD among NMUPO was modified by gender. An important 
finding of this study is that among NMPO users, women with less years of formal education 
are at significantly higher odds to progress to OD secondary to NMUPO, but this same risk 
was not observed in males. There was only weak evidence of a gender and educational 
attainment interaction among stimulant users. Prevention messages targeting women aged 
18–22 who have high school degrees but are not attending college and using POs are needed 
in order to prevent escalation to OD.
Also noteworthy is that among NH whites, having lower educational attainment was 
strongly associated with increased risk of NMUPO. However, among Hispanic young 
adults, all educational groups had similar low risk for NMUPO. That is, having a college 
education protects against NMUPO among NH whites but not among Hispanics. This is 
consistent with prior studies that show that NMUPO is more prevalent in rural regions of the 
U.S with a large proportion of NH whites where young adults have lower educational 
attainment and fewer returns on academic investment [64–67]. Associations between 
educational attainment and disorders among past year users of either nonmedical 
prescription opiate or stimulants did not significantly differ by race.
This study shows that, at least among young adults aged 18–22, the PO epidemic is not 
simply a phenomena occurring among NH whites in the US. While in this age group 
minorities seem to be less likely to use POs nonmedically than NH whites, past-year 
prevalence of OD among users is similar among Hispanics, Native-Americans, Asians, NH 
of more than one race and NH whites. There is evidence from other studies that young adults 
from NH white racial/ethnic groups could be particularly vulnerable to the consequences of 
having an OD. Data from national studies and from a sample of Midwestern college students 
indicate that Hispanics and NH whites are more likely to engage in NMUPO than NH 
blacks, and they are more likely to be recent-onset opioid users than NH blacks 
[68,69,43,70]. Patterns of persistent NMUPO use among Hispanics may be more severe than 
among NH whites: an analysis of NSDUH 2002–2003 data showed that Hispanics who 
recently began using PO nonmedically were almost two times more likely to persist using 
these drugs compared with NH whites [46]. Finally, recent urban data on PO overdose 
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mortality points to an increasing risk among Hispanics: while the rate of unintentional PO 
poisoning mortality increased 6% among NH blacks and 8% among NH whites in New 
York City in 2005–2009, the rate increased 75% among Hispanics in the same time period 
[71].
These findings have some strong implications as there are few NMUPO prevention 
programs tailored for young adults with less years of formal education—most prescription 
drug use prevention messages are targeted towards college students [30]. As such, 
prevention programs are also needed for non-college attending young adults, not only at the 
media level, but also in workplaces and other sites that young adult congregate. One of the 
few prevention programs designed to prevent nonmedical use of prescription drugs is a web-
based workplace program, the SmartRx [72] that has been tested among working women 
(mean age 44 years), but not specifically among large diverse samples of young adults. The 
program provides the pharmaceutical properties of the medications, instructions on the safe 
administration of the medications, and alternatives to medications with suggestions on ways 
to enhance users’ health and well-being [72]. Secondary prevention efforts should target 
non-college attending young adults to prevent the transition from nonmedical use to disorder 
among young adults who are already nonmedical prescription opioid and prescription 
stimulant users.
Limitations are noted. While large epidemiologic datasets are useful for examining factors 
associated with nonmedical prescription opioid use and prescription opioid disorder, we can 
at most infer associations using the cross-sectional design of this study. The surveys were 
based on self-report, but the use of computerized reporting system minimizes the impact of 
social desirability bias on reporting [73]. NSDUH data does not distinguish whether 
respondents were attending 2-year (community colleges) or 4-year colleges, which could 
potentially influence findings and needs to be further investigated in future studies. In 
addition, reasons males do not attend college versus reasons for females not to attend college 
might be different [74], and these differences might be associated with the development of 
nonmedical prescription drug use and disorders. Also, we could not distinguish whether 
these nonmedical prescription opioid users first started using these drugs when legitimately 
prescribed (e.g., pain relief) or when obtained illegally (e.g., to get high); such data were 
unavailable in the NSDUH. Moreover, another limitation of the NSDUH data is the fact that 
motives for use are not included in the questionnaire [75–77]. In addition, the lack of 
detailed data on psychiatric diagnosis is a limitation of the NSDUH data, as the K-6 scale is 
a proxy for psychological distress and does not reflect psychiatric diagnoses per se. 
Gathering such data in future studies will help us understand the profiles of these users, 
which may be distinct. Small cell sizes for some racial/ethnic groups, particularly when 
examining disorders, are a limitation. However, this study has also had several substantial 
strengths, including the rigorous NSDUH research design and data collection methods, large 
sample size and generalizability to the U.S young adult household population.
In conclusion, this study illustrates that young adults who do not attend college are at 
particularly high risk for nonmedical prescription opioid use and disorder. In contrast, the 
nonmedical use of prescription stimulants is higher among college-educated young adults. 
The influences of gender and race on these associations are important to consider. Higher 
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education may be a protective factor for some race/ethnic groups but not for others. There is 
a need for young adult prevention and intervention programs to target nonmedical 
prescription drug use beyond college campuses.
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